Invasive fungal infections;Inwazyjne zakażenia grzybicze

Mikologia Lekarska

Volumn 15, Issue 1, 2008, Pages 43-47

  Passowicz Muszyńska, Ewa ^a   Jankowska, Renata ^a   Kosacka, Monika ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antifungal agents; Immunocompromise; Invasive fungal infections

Indexed keywords

ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; GALACTOMANNAN;

ASPERGILLUS; CANDIDA; CRYPTOCOCCUS; DIAGNOSTIC TEST; FUNGUS CULTURE; FUSARIUM; HUMAN; IMMUNOCOMPROMISED PATIENT; MORBIDITY; MORTALITY; MYCOSIS; NONHUMAN; REVIEW; TRICHOSPORON; ZYGOMYCETES;

EID: 42549126961     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Grigg A.: Propphylaxis and treatment of patients with aspergillosis: an overview, including the Royal Melburne Hospital experience. J. Antimicrob. Chemother., 2002, 49, 75-80.
2. Abi-Said D., Anaissie E., Uzon O., Raadi I., Pinzcowski H., Vartivarian S.: The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis., 1997, 24, 6, 1122-1128.
3. th Annual Meeting of the Infectious Diseases Society of America, 1997, Abstract 13.
4. Sobel J.D.: Management of asymptomatic candiduria. Int. J. Antimicrob. Agents, 1999, 11, 285-288.
5. Berenguer J., Buck M., Witebsky F., Stock F., Pizzo P,A., Walsh T.J.: Lysis - centrifufugation blood cultures in the detection of tissue proven invasive candidiasis. Dissemi-nated versus single organ infection. Diagn. Microbiol. Infect. Dis., 1993, 17, 103-109.
6. Morrison V.A., Haake R.J., Weisdorf D.J.: Non-Candida fungal infections after bone morrow transplantation: risk factors and outcome. Am. J. Med., 1994, 96, 497-503.
7. Doffman S.R., Agrawal S.G., Browan J.S.: Invasive pulmonary aspergillosis. Expert. Rev. Anti. Infect Ther., 2005, 3, 613-627.
8. Mattner F., Chaberny I.F., Weissbrodt H., Fischer S., Gastmeier P., Haubitz B., Gottlieb J., Mattner L., Strueber M.: Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole. Mycoses, 2005, 58, suppl. 1, 51-55.
9. Abbasi S., Shenep J.L., Hughes W.T., Flynn P.M.: Aspergillosis in children with cancer. A 34-year experience. Clin. Infect. Dis., 1999, 29, 1210-1219.
10. Wallace J.M., Lim R., Browdy B.L., Hopewell P.C., Rosen M.J., Reichman L.B., Kvale P.A.: Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest, 1998, 114, 131-137.
11. Iwen P.C., Reed E.C., Armitage J.O., Bierman P.J., Kessinger A., Vose M., Ameson M.A., Winfield B.A., Woods G.L.: Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripherial stem cell transplants. Infect. Control Hosp. Epidemiol., 1993, 14, 131-139.
12. th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1996, New Orleans.
13. Bushelman S.J., Callen J.P., Roth D.N., Cohen L.M.: Disseminated Fusarium solani infection. J. Am. Acad. Dermatol., 1995, 32, 346-351.
14. Krcmery V, Jr, Mateicka F., Kunova A., Spanik S., Gyarfas J., Sycova Z., Trupl J.: Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazole. Support Care Cancer, 1997, 7, 39-43.
15. Chen J., Fraser T., Fischer D., Khalil Z., Collins M., Hafner L.: Characteristic of fungal growth in soft contact lenses. Int. Contact Lens Clin., 2000, 26, 84-91.
16. Abdala E., Lopes R.I., Chaves C.N., Heins-Vaccan E.M., Shikanai-Yasuda M.A.: Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl. Infect. Dis., 2005, 7, 162-165.
17. Horvath J.A., Dummer S.: The use of respiratory-tract cultures in the diagnosis of invasive pilmonary aspergillosis. Am. J. Med., 1996, 100, 171-178.
18. Blum U., Windfuhr M., Buitargo-Tellez C., Sigmund G., Herbst E.W., Langer M.: Invasive pulmonary aspergillosis: MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest, 1994, 106, 1156-1161.
19. Jankowska-Konsur A., Baran E., Jankowska R.: Grzybice płuc. Mikol. Lek., 2005, 12, 193-196.
20. Pinto P.S.: The CT halo sign. Radiol., 2004, 230, 109-110.
21. Caillot D., Casasnovas O., Bernard A., Couailler J.F., Durand C., Cuisenier B., Solary E., Piard F., Petrella T., Bonnin A., Couillault G., Dumas M., Guy H.: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J. Clin. Oncol., 1997, 15, 139-147.
22. Scotter J.M., Campbell P., Anderson T.P., Murdoch D.R., Chambers S.T., Patton W.N.: Comparison of PCR-Elisa and galactomann detection for the diagnosis of invasive asperhillosis. Pathology, 2005, 37, 246-253.
23. Hope W.W., Walsh T.J., Dennig D.W.: Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis., 2005, 5, 609-622.
24. Patterson T.F. Miniter P., Patterson J.E.: Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J. Infect. Dis., 1995, 17, 1553-1558.
25. Buchheidt D., Baust C., Skladny H., Ritter J., Suedhoff T., Baldus M., Seifarth W., Leib-Moesch C., Hehlmann R.: Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin. Infect. Dis., 2001, 33, 428-435.
26. Hebart H., Bollinger C., Fisch P., Sarfati J., Meisner C., Baur M., Loeffler J., Monod M., Latage J.P., Einsele H.: Analysis of T-cell responses to Aspergillus fumigatus antigen in healthy individual and patients with hematologic malignancies. Blood, 2002, 100, 4521-4528.
27. Yamakami Y., Hashimoto A., Yamagata E., Kamberi R., Nagai H., Nasu M.: Evaluation of PCR for detection of DNA specific for aspergillus species in sera of patients with various forms of pulmonary aspergillosis. J. Clin. Microbiol., 1998, 36, 3619-3623.
28. Maertens J., Verhaegen J., Lagrou K., Van Eldere J., Boogaerts M.: Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood, 2001, 97, 1604-1610.
29. Becker M.J., de Marie S., Willemse D., Verbrugh H.A., Bakker-Woudenberg I.A.: Quantitative galactomannan detection in superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J. Clin. Microbiol., 2000, 38, 1434-1438.
30. White P.L., Archer A.E., Bames R.A.: Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J. Clin. Microbiol., 2005, 43, 181-182, 187.